Clinical Trial Update: A Study to Assess the Bioavailability of Different Formulations of AZD5718 and the Food Effect on the Selected Formulation of AZD5718 in Healthy Volunteers [Phase 1]

View source ↗

Summary

A Phase 1 study to assess the bioavailability of different AZD5718 formulations and the effect of food on the selected formulation in healthy volunteers (comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• AZD5718 (AZD5718)

Snippet

Sponsor: AstraZeneca | Conditions: Coronary Artery Disease | Phase 1 | Status: COMPLETED